Trial Site Detail

 

Drug:
QINLOCK Ripretinib DCC-2618
Trial:
Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies (invictus)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Istituto Nazionale Dei Tumori

via Giacomo     
Milan , 20133
Italy

 

Principal Investigator:
Paolo Casali MD
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Istituto Nazionale Dei Tumori Website:
http://www.istitutotumori.mi.it/INT/default.asp

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.